PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Colestyramine - Bile acid malabsorption
PAD Profile : Colestyramine - Bile acid malabsorption
Keywords :
BAM, bile salt absorption, bile acid sequestrants, bile acid diarrhoea
Brand Names Include :
Questran, Questran Light
Traffic Light Status
Status 1 of 2.
Status :
Blue
Important
Preferred
Formulations :
- Sachets (powder)
Important Information :
These are the recommended 1st line treatment option (ordinary sachets, with sugar)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Blue
Important
Formulations :
- Sachets (SUGAR FREE powder)
Important Information :
3rd line colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation.
The ordinary powder sachets are 1st line.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the following traffic light statuses and place in therapy for treatments used in Bile Acid Malabsorption (BAM)
BLUE traffic light status (on recommendation by a specialist)
· 1st line colestyramine (with sugar)
· 2nd line colesevelam
· 3rd colestyramine (sugar free) – for diabetic patients who request a sugar free formulation. Most costly preparation
A patient information leaflet is available - see Documentation
Associated BNF Codes
01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow